Immunoglobulin E (IgE), originally described in 1967 by Ishizaka et al,[1] is well established to be important in atopic disorders such as asthma, allergic rhinitis, food allergies, and atopic dermatitis. This evidence concerns the gene IGHE and allergic rhinitis.